ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
US Market

ANI Pharmaceuticals (ANIP) Income Statement

Compare
295 Followers

ANI Pharmaceuticals Income Statement

Last quarter (Q4 2024), ANI Pharmaceuticals's total revenue was $190.57M, an increase of 44.75% from the same quarter last year. In Q4, ANI Pharmaceuticals's net income was $-10.28M. See ANI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 614.38M$ 486.82M$ 316.38M$ 216.14M$ 208.47M
Gross Profit
$ 614.38M$ 305.30M$ 177.60M$ 115.53M$ 121.32M
Operating Expenses
$ 613.79M$ 258.33M$ 203.33M$ 143.69M$ 136.89M
Depreciation and Amortization
$ 67.73M$ 59.79M$ 56.97M$ 47.25M$ 44.64M
EBITDA
$ 63.12M$ 106.60M$ 48.07M$ -1.68M$ 29.07M
Operating Income
$ 584.00K$ 46.97M$ -25.06M$ -32.51M$ -16.06M
Other Income/Expenses
$ -22.80M$ -27.10M$ -27.38M$ -16.27M$ -9.95M
Pretax Income
$ -22.21M$ 19.87M$ -62.66M$ -56.06M$ -25.96M
Net Income
$ -18.52M$ 18.78M$ -47.90M$ -42.60M$ -22.55M
Per Share Metrics
Basic EPS
$ -0.87$ 0.95$ -2.95$ -3.38$ -1.88
Diluted EPS
$ -0.87$ 0.94$ -2.95$ -3.38$ -1.88
Weighted Average Shares Outstanding
19.32M 18.00M 16.26M 12.60M 11.96M
Weighted Average Shares Outstanding (Diluted)
19.32M 18.19M 16.26M 12.60M 11.96M
Currency in USD

ANI Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis